Citius Oncology (CTOR) Other Operating Expenses (2023 - 2026)
Citius Oncology (CTOR) posted quarterly Other Operating Expenses of $4.7 million for Q1 2026, up 207.71% year-over-year from $1.5 million in Q1 2025, and up 16.06% quarter-over-quarter from $4.0 million in Q4 2025.
Citius Oncology (CTOR) Other Operating Expenses (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Other Operating Expenses for 4 consecutive years, with $4.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses rose 207.71% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $8.2 million (down 13.21% YoY), while the FY2025 annual figure was $6.1 million, down 28.97% from the prior year.
- Other Operating Expenses improved to $4.7 million in Q1 2026 per CTOR's latest filing, from $4.0 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $6.6 million in Q2 2024 and bottomed at -$2.1 million in Q3 2025.
- Historically, Other Operating Expenses has averaged $2.5 million across 4 years, with a median of $2.2 million in 2023.
- On a YoY basis, Other Operating Expenses climbed as much as 224.98% in 2025 and fell as far as 76.57% in 2025.
- Citius Oncology's Other Operating Expenses stood at $2.2 million in 2023, then tumbled by 42.57% to $1.2 million in 2024, then jumped by 224.98% to $4.0 million in 2025, then advanced by 16.06% to $4.7 million in 2026.
- Business Quant data shows CTOR's Other Operating Expenses at $4.7 million in Q1 2026, $4.0 million in Q4 2025, and -$2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Citius Oncology | 76.95 Mn | 76.95 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.68 Mn |
| Dec 31, 2025 | 4.03 Mn |
| Sep 30, 2025 | -2.10 Mn |
| Jun 30, 2025 | 1.56 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 1.24 Mn |
| Jun 30, 2024 | 6.65 Mn |
| Mar 31, 2024 | 3.02 Mn |
| Dec 31, 2023 | 2.16 Mn |